X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (XFOR)

Q: What does CUSIP 98420X103 represent in this 13F holders report?

CUSIP 98420X103 is the security identifier for XFOR - X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held XFOR - X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in Q1 2021?

59 institutional investors reported XFOR - X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share for Q1 2021. Use the holders table for investor-level position and value details.

CUSIP: 98420X103

Q1 2021 13F Holders as of 31 Mar 2021

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 16,126,888
Total 13F value: $138,720,293
Share change: +5,649,108
SEC-reported price per share: $8.61
Number of holders: 59
Value change: +$48,924,159
Number of buys: 30
Number of sells: 19
Shares outstanding: 94,372,096

Security key

98420X103

Report period

Q1 2021

Institutions

Top holders

XFOR full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 X4 Pharmaceuticals, Inc SEC filings X4 Pharmaceuticals, Inc company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 98420X103

Newer quarter: Q3 2025

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of XFOR - X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Bain Capital Life Science...

Disclosed value leader

Bain Capital Life Science...

Comparable rows

0/15

Latest evidence

31 Dec 2020

13F Highest disclosed value: $10,600,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Bain Capital Life Sciences Investors, LLC has the largest disclosed position value at $10.6M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bain Capital Life Sciences Investors, LLC's linked filing trail.

Disclosed position value Top 5

Bain Capital Life Sciences Invest... $10.6M

ORBIMED ADVISORS LLC $6.99M

BlackRock Finance, Inc. $6.64M

Ikarian Capital, LLC $5.31M

BVF INC/IL $5.1M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Bain Capital Life Sciences Investors, LLC	13F Company 13F	— denominator unverified	$10,600,000 1,648,485 shares	—	31 Dec 2020
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$6,986,000 1,086,493 shares	—	31 Dec 2020
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$6,645,000 1,033,503 shares	—	31 Dec 2020
Ikarian Capital, LLC	13F Company 13F	— denominator unverified	$5,314,000 826,424 shares	—	31 Dec 2020
BVF INC/IL	13F Company 13F	— denominator unverified	$5,098,000 792,892 shares	—	31 Dec 2020
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$4,726,000 734,966 shares	—	31 Dec 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

16,126,888

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q1 2026 Across Filers

Q1 2026 holders

Q1 2021 holders

Holder diff

Investor	Q1 2026 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q1 2026 value	Q1 2021 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend